Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a special purpose acquisition company sponsored by Forbion, a European life sciences venture capital firm headquartered in the Netherlands with a long track record of backing biopharmaceutical and medical technology companies across Europe. The SPAC completed its initial public offering in December 2021, raising capital to pursue a business combination with a target in the European healthcare and life sciences sector. Forbion's deep domain expertise in drug development and biotech positioned FRBN as a sector-specialist vehicle at a time of elevated SPAC activity in the life sciences space. For full deal history, filing details, and real-time status on FRBN, create a free account at SpacDesk.